Brief Article
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2012; 18(47): 7056-7062
Published online Dec 21, 2012. doi: 10.3748/wjg.v18.i47.7056
Figure 1
Figure 1 IS-IV of patients under radical or palliative treatment. All 81 patients had suffered from stage IV pancreatic cancer and died before October of 2011. There were 51 patients in the radical treatment group, and 30 patients in the palliative treatment group. The median follow-up period was 8 mo. The IS-IV of patients was accumulated from the early diagnosis of stage IV pancreatic cancer in our own or other hospitals.
Figure 2
Figure 2 IS-IV of patients under timely or delayed treatment. A: Comparison between patients in the radical treatment group: 32 patients under timely treatment and 18 patients under delayed treatment; B: Comparison between patients in the palliative treatment group: 22 patients under timely treatment and 9 patients under delayed treatment.
Figure 3
Figure 3 IS-IV of patients under different treatment frequency. A: Comparison among patients in radical treatment group, 17 patients under multiple radical treatment (2 times, by 10 patients; 3 times, by 4 patients; 4, 5 and 9 times, by 1 patient each) and 33 patients were under single radical treatment; B: Comparison among patients in palliative treatment group, 14 patients under multiple palliative treatment (2 times, by 11 patients; 3 times, by 3 patients) and 17 patients under single palliative treatment.